Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

[Guidelines for the macroscopic management of surgically resected lung carcinoma].

Mansuet-Lupo A, Filaire M, Chaffanjon P, Alifano M, Forest F, Gibault L, Vignaud JM, Brevet M, Hofman V, Rouquette I, Antoine M, Cazes A, Damotte D, Lantuejoul S; pour le groupe de pathologistes thoraciques de valorisation de l’expertise, de la recherche et de l’innovation (PATTERN), Fondation Synergie Lyon Cancer.

Ann Pathol. 2019 Oct 8. pii: S0242-6498(19)30106-3. doi: 10.1016/j.annpat.2019.05.008. [Epub ahead of print] French.

PMID:
31604575
2.

Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma.

Nassereddine H, Sannier A, Brosseau S, Rodier JM, Khalil A, Msika S, Danel C, Couvelard A, Théou-Anton N, Cazes A.

Pathol Oncol Res. 2019 Aug 12. doi: 10.1007/s12253-019-00713-1. [Epub ahead of print]

PMID:
31407221
3.

Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease.

Le Joncour A, Martos R, Loyau S, Lelay N, Dossier A, Cazes A, Fouret P, Domont F, Papo T, Jandrot-Perrus M, Bouton MC, Cacoub P, Ajzenberg N, Saadoun D, Boulaftali Y.

Ann Rheum Dis. 2019 Sep;78(9):1274-1282. doi: 10.1136/annrheumdis-2018-214335. Epub 2019 May 30.

PMID:
31147357
4.

Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer.

Assoun S, Theou-Anton N, Nguenang M, Cazes A, Danel C, Abbar B, Pluvy J, Gounant V, Khalil A, Namour C, Brosseau S, Zalcman G.

Lung Cancer. 2019 Jun;132:65-71. doi: 10.1016/j.lungcan.2019.04.005. Epub 2019 Apr 8.

PMID:
31097096
5.

MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages.

Babicky ML, Harper MM, Chakedis J, Cazes A, Mose ES, Jaquish DV, French RP, Childers B, Alakus H, Schmid MC, Foubert P, Miyamoto J, Holman PJ, Walterscheid ZJ, Tang CM, Varki N, Sicklick JK, Messer K, Varner JA, Waltz SE, Lowy AM.

Oncogene. 2019 Jul;38(28):5599-5611. doi: 10.1038/s41388-019-0811-9. Epub 2019 Apr 9.

6.

CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis.

JanWillem D, Lin C, Moog S, Jaillet M, Castier Y, Cazes A, Borensztajn KS, Crestani B, Spek CA.

J Clin Transl Res. 2018 Feb 21;3(Suppl 2):358-365. eCollection 2018 Jul 30.

7.

C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study.

Ngo C, Danel C, Duong-Quy S, Dauriat G, Castier Y, Lortat-Jacob B, Mal H, Brugière O, Cazes A.

Histopathology. 2019 Jun;74(7):988-996. doi: 10.1111/his.13823. Epub 2019 Apr 1.

PMID:
30636056
8.

Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes.

Borie R, Bouvry D, Cottin V, Gauvain C, Cazes A, Debray MP, Cadranel J, Dieude P, Degot T, Dominique S, Gamez AS, Jaillet M, Juge PA, Londono-Vallejo A, Mailleux A, Mal H, Boileau C, Menard C, Nunes H, Prevot G, Quetant S, Revy P, Traclet J, Wemeau-Stervinou L, Wislez M, Kannengiesser C, Crestani B.

Eur Respir J. 2019 Feb 7;53(2). pii: 1800508. doi: 10.1183/13993003.00508-2018. Print 2019 Feb.

PMID:
30523160
9.

A 56-Year-Old Man With Cardiac Tamponade and Eosinophilia.

David C, Cazes A, Dossier A, Pasi N, Tadros VX, Papo T, Sacre K.

Chest. 2018 Dec;154(6):e173-e176. doi: 10.1016/j.chest.2018.06.031.

PMID:
30526985
10.

Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome.

Brugière O, Roux A, Le Pavec J, Sroussi D, Parquin F, Pradère P, Dupin C, Bunel V, Mourin G, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Mal H, Suberbielle C, Gautreau C, Caillat-Zucman S, Cazes A, Thabut G, Taupin JL.

Eur Respir J. 2018 Aug 23;52(2). pii: 1701898. doi: 10.1183/13993003.01898-2017. Print 2018 Aug.

PMID:
29976654
11.

Clinical and molecular characteristics of unicentric mediastinal Castleman disease.

Legras A, Tallet A, Didelot A, Cazes A, Danel C, Hin A, Borie R, Crestani B, Castier Y, Bagan P, Le Pimpec-Barthes F, Riquet M, Blons H, Mordant P.

J Thorac Dis. 2018 Apr;10(4):2079-2088. doi: 10.21037/jtd.2018.03.159.

12.

[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].

Lantuejoul S, Adam J, Girard N, Duruisseaux M, Mansuet-Lupo A, Cazes A, Rouquette I, Gibault L, Garcia S, Antoine M, Vignaud JM, Galateau-Sallé F, Sagan C, Badoual C, Penault-Llorca F, Damotte D; pour le groupe pathologistes thoraciques de valorisation de l’expertise, de la recherche et de l’innovation (PATTERN). Fondation Synergie Lyon Cancer.

Ann Pathol. 2018 Apr;38(2):110-125. doi: 10.1016/j.annpat.2018.01.007. Epub 2018 Mar 21. French.

PMID:
29571563
13.

Fulminant Acute Respiratory Distress Syndrome After Calcineurin Inhibitor-belatacept Conversion in a Lung Transplant Recipient.

Brugière O, Cazes A, Champion L, Debray MP, Mourin G, Crestani B, Sroussi D, Bunel V, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Bouadma L, Mal H, Thabut G.

Transplantation. 2018 Jun;102(6):e255-e256. doi: 10.1097/TP.0000000000002153. No abstract available.

PMID:
29509571
14.

Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients.

Beltramo G, Thabut G, Peron N, Nicaise P, Cazes A, Debray MP, Joannes A, Castier Y, Mailleux AA, Frija J, Pradère P, Justet A, Borie R, Dombret MC, Taille C, Aubier M, Crestani B.

Respir Med. 2018 Feb;135:15-21. doi: 10.1016/j.rmed.2017.12.011. Epub 2018 Jan 2.

PMID:
29414448
15.

Physiology of the lung in idiopathic pulmonary fibrosis.

Plantier L, Cazes A, Dinh-Xuan AT, Bancal C, Marchand-Adam S, Crestani B.

Eur Respir Rev. 2018 Jan 24;27(147). pii: 170062. doi: 10.1183/16000617.0062-2017. Print 2018 Mar 31. Review.

16.

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer.

Adam J, Le Stang N, Rouquette I, Cazes A, Badoual C, Pinot-Roussel H, Tixier L, Danel C, Damiola F, Damotte D, Penault-Llorca F, Lantuéjoul S.

Ann Oncol. 2018 Apr 1;29(4):953-958. doi: 10.1093/annonc/mdy014.

PMID:
29351573
17.

Pneumocystosis revealing immunodeficiency secondary to TERC mutation.

Borie R, Kannengiesser C, Sicre de Fontbrune F, Boutboul D, Tabeze L, Brunet-Possenti F, Lainey E, Debray MP, Cazes A, Crestani B.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701443. doi: 10.1183/13993003.01443-2017. Print 2017 Nov. No abstract available.

18.

Human airway trypsin-like protease exerts potent, antifibrotic action in pulmonary fibrosis.

Menou A, Flajolet P, Duitman J, Justet A, Moog S, Jaillet M, Tabèze L, Solhonne B, Garnier M, Mal H, Mordant P, Castier Y, Cazes A, Sallenave JM, Mailleux AA, Crestani B.

FASEB J. 2018 Mar;32(3):1250-1264. doi: 10.1096/fj.201700583R. Epub 2018 Jan 3.

PMID:
29122847
19.

The pro-apoptotic BAX protein influences cell growth and differentiation from the nucleus in healthy interphasic cells.

Brayer S, Joannes A, Jaillet M, Gregianin E, Mahmoudi S, Marchal Sommé J, Fabre A, Mordant P, Cazes A, Crestani B, Mailleux AA.

Cell Cycle. 2017;16(21):2108-2118. doi: 10.1080/15384101.2017.1371882. Epub 2017 Sep 21.

20.

Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.

Brosseau S, Gounant V, Naltet C, Théou-Anton N, Cazes A, Smonig R, Neuville M, Khalil A, Mikail N, Meignin V, Bergeron A, Zalcman G.

Clin Lung Cancer. 2018 Jan;19(1):e57-e61. doi: 10.1016/j.cllc.2017.07.003. Epub 2017 Aug 3. No abstract available.

PMID:
28844392
21.

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway.

Saint-Criq V, Villeret B, Bastaert F, Kheir S, Hatton A, Cazes A, Xing Z, Sermet-Gaudelus I, Garcia-Verdugo I, Edelman A, Sallenave JM.

Thorax. 2018 Jan;73(1):49-61. doi: 10.1136/thoraxjnl-2017-210298. Epub 2017 Aug 8.

22.

[Hot lung nodules on PET-CT].

Sannier A, Cazes A, Mordant P, Boutboul D, Borie R, Danel C.

Ann Pathol. 2017 Aug;37(4):327-331. doi: 10.1016/j.annpat.2017.06.001. Epub 2017 Jul 25. Review. French. No abstract available.

PMID:
28754215
23.

Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment.

Pluvy J, Brosseau S, Naltet C, Opsomer MA, Cazes A, Danel C, Khalil A, Zalcman G, Gounant V.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700310. doi: 10.1183/13993003.00310-2017. Print 2017 Jul. No abstract available.

24.

FGF9 prevents pleural fibrosis induced by intrapleural adenovirus injection in mice.

Justet A, Joannes A, Besnard V, Marchal-Sommé J, Jaillet M, Bonniaud P, Sallenave JM, Solhonne B, Castier Y, Mordant P, Mal H, Cazes A, Borie R, Mailleux AA, Crestani B.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L781-L795. doi: 10.1152/ajplung.00508.2016. Epub 2017 Jul 20.

25.

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses.

Guyard A, Danel C, Théou-Anton N, Debray MP, Gibault L, Mordant P, Castier Y, Crestani B, Zalcman G, Blons H, Cazes A.

Respir Res. 2017 Jun 15;18(1):120. doi: 10.1186/s12931-017-0605-y.

26.

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects.

Pernot S, Badoual C, Terme M, Castan F, Cazes A, Bouche O, Bennouna J, Francois E, Ghiringhelli F, De La Fouchardiere C, Samalin E, Bachet JB, Borg C, Ducreux M, Marcheteau E, Stanbury T, Gourgou S, Malka D, Taieb J.

Eur J Cancer. 2017 Jul;79:15-22. doi: 10.1016/j.ejca.2017.03.036. Epub 2017 Apr 26.

PMID:
28456090
27.

Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series.

Philippot Q, Cazes A, Borie R, Debray MP, Danel C, Hurtado Nedelec M, Boudjemaa S, Sroussi D, Dupin C, Mal H, Dauriat G, Jean-Baptiste S, Jebrak G, Castier Y, Mordant P, Thabut G, Brugière O.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601369. doi: 10.1183/13993003.01369-2016. Print 2017 Feb. No abstract available.

28.

Atrial angioleiomyoma with myopericytoma-like features: a case report.

Nassereddine H, Cazes A, Verdonk C, Assous B, Dautry R, Nataf P, Wassef M, Deschamps L.

Cardiovasc Pathol. 2017 May - Jun;28:7-10. doi: 10.1016/j.carpath.2017.02.001. Epub 2017 Feb 8.

PMID:
28219756
29.

[Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].

Duruisseaux M, Rouquette I, Adam J, Cortot A, Cazes A, Gibault L, Damotte D, Lantuejoul S.

Ann Pathol. 2017 Feb;37(1):61-78. doi: 10.1016/j.annpat.2016.12.009. Epub 2017 Feb 3. Review. French.

PMID:
28162296
30.

68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.

Provost C, Prignon A, Cazes A, Combaret V, Delattre O, Janoueix-Lerosey I, Montravers F, Talbot JN.

Anticancer Res. 2016 Sep;36(9):4459-66.

PMID:
27630282
31.

Metabolism in melanoma metastasis.

Cazes A, Ronai ZA.

Pigment Cell Melanoma Res. 2016 Mar;29(2):118-9. doi: 10.1111/pcmr.12440. Epub 2015 Dec 18. No abstract available.

PMID:
26575789
32.

Plastic Bronchitis Related to Idiopathic Thoracic Lymphangiectasia. Noncontrast Magnetic Resonance Lymphography.

El Mouhadi S, Taillé C, Cazes A, Arrivé L.

Am J Respir Crit Care Med. 2015 Sep 1;192(5):632-3. No abstract available.

PMID:
26561678
33.

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment.

Lambertz I, Kumps C, Claeys S, Lindner S, Beckers A, Janssens E, Carter DR, Cazes A, Cheung BB, De Mariano M, De Bondt A, De Brouwer S, Delattre O, Gibbons J, Janoueix-Lerosey I, Laureys G, Liang C, Marchall GM, Porcu M, Takita J, Trujillo DC, Van Den Wyngaert I, Van Roy N, Van Goethem A, Van Maerken T, Zabrocki P, Cools J, Schulte JH, Vialard J, Speleman F, De Preter K.

Clin Cancer Res. 2015 Jul 15;21(14):3327-39. doi: 10.1158/1078-0432.CCR-14-2024. Epub 2015 Mar 24.

34.

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer.

Giraldo NA, Becht E, Pagès F, Skliris G, Verkarre V, Vano Y, Mejean A, Saint-Aubert N, Lacroix L, Natario I, Lupo A, Alifano M, Damotte D, Cazes A, Triebel F, Freeman GJ, Dieu-Nosjean MC, Oudard S, Fridman WH, Sautès-Fridman C.

Clin Cancer Res. 2015 Jul 1;21(13):3031-40. doi: 10.1158/1078-0432.CCR-14-2926. Epub 2015 Feb 16.

35.

An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.

Orth MF, Cazes A, Butt E, Grunewald TG.

Oncotarget. 2015 Jan 1;6(1):26-42. Review.

36.

Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway.

Smadja DM, Dorfmüller P, Guerin CL, Bieche I, Badoual C, Boscolo E, Kambouchner M, Cazes A, Mercier O, Humbert M, Gaussem P, Bischoff J, Israël-Biet D.

Thromb Haemost. 2014 Nov;112(5):1002-13. doi: 10.1160/TH13-08-0711. Epub 2014 Aug 7.

37.

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.

Cazes A, Lopez-Delisle L, Tsarovina K, Pierre-Eugène C, De Preter K, Peuchmaur M, Nicolas A, Provost C, Louis-Brennetot C, Daveau R, Kumps C, Cascone I, Schleiermacher G, Prignon A, Speleman F, Rohrer H, Delattre O, Janoueix-Lerosey I.

Oncotarget. 2014 May 15;5(9):2688-702.

38.

[Lymphatic extension and lymphangiogenesis in non-small cell lung cancer].

Cazes A, Gibault L, Rivera C, Mordant P, Riquet M.

Rev Pneumol Clin. 2014 Feb-Apr;70(1-2):26-31. doi: 10.1016/j.pneumo.2013.09.008. Epub 2014 Feb 22. Review. French.

PMID:
24566036
39.

[Molecular profiling of non-small cell lung cancer].

Gibault L, Cazes A, Narjoz C, Blons H.

Rev Pneumol Clin. 2014 Feb-Apr;70(1-2):47-62. doi: 10.1016/j.pneumo.2013.11.005. Epub 2014 Feb 22. Review. French.

PMID:
24566035
40.

[Idiopathic pulmonary fibrosis: diagnosis and treatment in 2013].

Israël-Biet D, Juvin K, Dang Tran K, Badia A, Cazes A, Delclaux C.

Rev Pneumol Clin. 2014 Feb-Apr;70(1-2):108-17. doi: 10.1016/j.pneumo.2013.12.004. Epub 2014 Feb 22. Review. French.

PMID:
24566024
41.

Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.

de Reyniès A, Jaurand MC, Renier A, Couchy G, Hysi I, Elarouci N, Galateau-Sallé F, Copin MC, Hofman P, Cazes A, Andujar P, Imbeaud S, Petel F, Pairon JC, Le Pimpec-Barthes F, Zucman-Rossi J, Jean D.

Clin Cancer Res. 2014 Mar 1;20(5):1323-34. doi: 10.1158/1078-0432.CCR-13-2429. Epub 2014 Jan 17.

42.

Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.

Vieira T, Girard N, Ung M, Monnet I, Cazes A, Bonnette P, Duruisseaux M, Mazieres J, Antoine M, Cadranel J, Wislez M.

J Thorac Oncol. 2013 Dec;8(12):1574-7. doi: 10.1097/01.JTO.0000437008.00554.90.

43.

[Lymphatics and lung transplantation. A review].

Le Pimpec-Barthes F, Mordant P, Pricopi C, Gibaud L, Arame A, Cazes A, Badia A, Hernigou A, Riquet M.

Rev Pneumol Clin. 2014 Feb-Apr;70(1-2):32-7. doi: 10.1016/j.pneumo.2013.06.002. Epub 2013 Oct 31. Review. French.

PMID:
24183293
44.

[Radiofrequency of lung metastases: should initial pneumothorax predict treatment failure?].

Legras A, Mordant P, Cazes A, Riquet M.

Rev Pneumol Clin. 2013 Dec;69(6):336-9. doi: 10.1016/j.pneumo.2013.04.008. Epub 2013 Sep 17. French.

PMID:
24051188
45.

Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis.

Boeva V, Jouannet S, Daveau R, Combaret V, Pierre-Eugène C, Cazes A, Louis-Brennetot C, Schleiermacher G, Ferrand S, Pierron G, Lermine A, Rio Frio T, Raynal V, Vassal G, Barillot E, Delattre O, Janoueix-Lerosey I.

PLoS One. 2013 Aug 26;8(8):e72182. doi: 10.1371/journal.pone.0072182. eCollection 2013.

46.

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

Tallet A, Nault JC, Renier A, Hysi I, Galateau-Sallé F, Cazes A, Copin MC, Hofman P, Andujar P, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D.

Oncogene. 2014 Jul 10;33(28):3748-52. doi: 10.1038/onc.2013.351. Epub 2013 Aug 26.

PMID:
23975423
47.

Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.

Tible M, Loupy A, Vernerey D, Suberbielle C, Beuscart T, Cazes A, Guillemain R, Amrein C, Pezzella V, Fabiani JN, Nochy D, Hill G, Empana JP, Jouven X, Charron D, Bruneval P, Duong Van Huyen JP.

J Heart Lung Transplant. 2013 Aug;32(8):769-76. doi: 10.1016/j.healun.2013.05.012.

PMID:
23856214
48.

Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.

Remark R, Alifano M, Cremer I, Lupo A, Dieu-Nosjean MC, Riquet M, Crozet L, Ouakrim H, Goc J, Cazes A, Fléjou JF, Gibault L, Verkarre V, Régnard JF, Pagès ON, Oudard S, Mlecnik B, Sautès-Fridman C, Fridman WH, Damotte D.

Clin Cancer Res. 2013 Aug 1;19(15):4079-91. doi: 10.1158/1078-0432.CCR-12-3847. Epub 2013 Jun 19.

49.

High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.

Grand B, Cazes A, Mordant P, Foucault C, Dujon A, Guillevin EF, Barthes FLP, Riquet M.

Lung Cancer. 2013 Sep;81(3):404-409. doi: 10.1016/j.lungcan.2013.05.008. Epub 2013 Jun 14.

PMID:
23769675
50.

Should all cases of lung cancer be presented at Tumor Board Conferences?

Riquet M, Mordant P, Henni M, Wermert D, Fabre-Guillevin E, Cazes A, Le Pimpec Barthes F.

Thorac Surg Clin. 2013 May;23(2):123-8. doi: 10.1016/j.thorsurg.2013.01.003. Epub 2013 Feb 4. Review.

PMID:
23566964

Supplemental Content

Support Center